tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BRNS Stock Latest News

Barinthus Biotherapeutics Receives Nasdaq Minimum Bid Price Notice
Company AnnouncementsBarinthus Biotherapeutics Receives Nasdaq Minimum Bid Price Notice
10d ago
8K
BRNS
Promising Clinical Trial Results and Strategic Merger Drive Buy Rating for Barinthus Biotherapeutics
PremiumRatings
Promising Clinical Trial Results and Strategic Merger Drive Buy Rating for Barinthus Biotherapeutics
1M ago
BRNS
Barinthus Biotherapeutics Updates on AVALON Trial Progress
PremiumCompany Announcements
Barinthus Biotherapeutics Updates on AVALON Trial Progress
1M ago
8K
BRNS
Barinthus Biotherapeutics announces update on Phase 1 trial of VTP-1000
PremiumThe Fly
Barinthus Biotherapeutics announces update on Phase 1 trial of VTP-1000
1M ago
BRNS
Buy Rating for Barinthus Biotherapeutics: Promising Clinical Developments and Strategic Merger with Clywedog Therapeutics
PremiumRatings
Buy Rating for Barinthus Biotherapeutics: Promising Clinical Developments and Strategic Merger with Clywedog Therapeutics
2M ago
BRNS
Barinthus Biotherapeutics price target raised to $4 from $3 at H.C. Wainwright
PremiumThe FlyBarinthus Biotherapeutics price target raised to $4 from $3 at H.C. Wainwright
2M ago
BRNS
Barinthus Biotherapeutics Reports Q3 2025 Earnings
Premium
Company Announcements
Barinthus Biotherapeutics Reports Q3 2025 Earnings
2M ago
BRNS
Barinthus Biotherapeutics reports Q3 EPS (36c) vs (21c) last year
Premium
The Fly
Barinthus Biotherapeutics reports Q3 EPS (36c) vs (21c) last year
2M ago
BRNS
Barinthus Biotherapeutics Advances Celiac Disease Treatment with VTP-1000 Trial
PremiumCompany Announcements
Barinthus Biotherapeutics Advances Celiac Disease Treatment with VTP-1000 Trial
3M ago
BRNS
Barinthus Biotherapeutics Announces Merger with Clywedog Therapeutics
PremiumCompany Announcements
Barinthus Biotherapeutics Announces Merger with Clywedog Therapeutics
4M ago
8K
BRNS
Barinthus Bio, Clywedog enter definitive merger agreement
PremiumThe Fly
Barinthus Bio, Clywedog enter definitive merger agreement
4M ago
BRNS
Barinthus Biotherapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
PremiumRatings
Barinthus Biotherapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
5M ago
BRNS
Barinthus Biotherapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsBarinthus Biotherapeutics Reports Q2 2025 Financial Results
5M ago
BRNS
Barinthus Biotherapeutics reports Q2 EPS (52c) vs. (49c) last year
Premium
The Fly
Barinthus Biotherapeutics reports Q2 EPS (52c) vs. (49c) last year
5M ago
BRNS
Barinthus Biotherapeutics sees cash runway into 2027
Premium
The Fly
Barinthus Biotherapeutics sees cash runway into 2027
5M ago
BRNS
Barinthus Biotherapeutics Approves Key Proposals at AGM
PremiumCompany Announcements
Barinthus Biotherapeutics Approves Key Proposals at AGM
7M ago
8K
BRNS
Barinthus Biotherapeutics: Strategic Advancements and Financial Strength Support Buy Rating
PremiumRatings
Barinthus Biotherapeutics: Strategic Advancements and Financial Strength Support Buy Rating
8M ago
BRNS
Barinthus Biotherapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Barinthus Biotherapeutics Reports Q1 2025 Financial Results
8M ago
BRNS
Barinthus Biotherapeutics Restructures Leadership with New CFO
PremiumCompany Announcements
Barinthus Biotherapeutics Restructures Leadership with New CFO
8M ago
8K
BRNS
Barinthus Biotherapeutics reports Q1 EPS (49c), consensus (36c)
PremiumThe FlyBarinthus Biotherapeutics reports Q1 EPS (49c), consensus (36c)
8M ago
BRNS
Barinthus Bio Reports 2024 Financial Results and Strategic Focus
Premium
Company Announcements
Barinthus Bio Reports 2024 Financial Results and Strategic Focus
10M ago
BRNS
Barinthus Biotherapeutics price target lowered to $6 from $7.50 at Alliance Global Partners
Premium
The Fly
Barinthus Biotherapeutics price target lowered to $6 from $7.50 at Alliance Global Partners
10M ago
BRNS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >